Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcome and characteristics of patients with adult grade 4 diffuse gliomas changing sites of treatment.

Journal of cancer research and clinical oncology - 1 Jan 2023

Forster Marie-Therese, Hug Marion, Geissler Maximilian, Voss Martin, Weber Katharina, Hoelter Maya Christina, Seifert Volker, Czabanka Marcus, Steinbach Joachim P

Abstract excerpt

PURPOSE: With increasing patient self-empowerment and participation in decision making, we hypothesized that patients with adult-type diffuse gliomas, CNS WHO grade 4 who change sites of treatment differ from patients being entirely treated in one neuro-oncological center. METHODS: Prospectively collected data from all diffuse glioma grade 4 patients who underwent treatment in our neuro-oncological center between...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Glioma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Mutation

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 36348019
DOI: 10.1007/s00432-022-04439-7
PMCID: PMC9889416

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcome and characteristics of patients with adult grade 4 diffuse gliomas changing sites of treatment.PMID 36348019Read ↗

Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year period.Semantic proximity Read ↗

Epidemiology and survival of adult-type diffuse glioma in Belgium during the molecular era.Semantic proximity Read ↗

National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States.Semantic proximity Read ↗

Clinical practice guidelines for the management of adult diffuse gliomas.Semantic proximity Read ↗

Clinical impact of revisions to the WHO classification of diffuse gliomas and associated future problems.Semantic proximity Read ↗

A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults.Semantic proximity Read ↗

Imaging features of localized IDH wild-type histologically diffuse astrocytomas: a single-institution case series.Semantic proximity Read ↗

IDH wild-type grade 2 diffuse astrocytomas: prognostic factors and impact of treatments within molecular subgroups.Semantic proximity Read ↗

Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.Semantic proximity Read ↗

Current Treatment Options for Adult Grade 2 IDH-mutant Diffuse Gliomas in the Vorasidenib Era: Patient Selection, Sequencing, and Practical Management.Semantic proximity Read ↗

Real-world clinical practice patterns in the surgical management of low-grade astrocytomas: An analysis of Surveillance, Epidemiology, and End Results (SEER) and the National Cancer Database (NCDB) databasesSemantic proximity Read ↗

Practice-Changing Abstracts From the 2016 Society for Neuro-Oncology Annual Scientific Meeting.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.